Conversely, Chi et al., reported that circulating CD33+CD11b+HLA-DR−CD14− granulocytic MDSCs represented the major subtype of MDSCs in patients with prostate cancer and their level were significantly elevated compared with both healthy donors and patients with benign prostatic hyperplasia (BPH) (190). This evidence concerns the gene ITGAM and benign prostatic hyperplasia.